Edilashvili Kartlos 4
4 · CALYPTE BIOMEDICAL CORP · Filed Jan 2, 2013
Insider Transaction Report
Form 4
CALYPTE BIOMEDICAL CORPCBMC.OB
Edilashvili Kartlos
Director
Transactions
- Award
Incentive Stock Option
2012-12-28+2,000,000→ 2,000,000 totalExercise: $0.03From: 2012-12-28Exp: 2022-12-27→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]The option was vested and exercisable as to 25% of the shares on the date of grant and continues to vest and become exercisable as to an additional 25% of the shares on each anniversary of the date of grant. In the event of termination of the optionee's employment under certain circumstances, the optionee will be credited with an additional six months of vesting.